

Everything you need to know about Zelsuvmi (berdazimer gel) — what it treats, how to use it, dosage instructions, cost, and where to find it in 2026.
Zelsuvmi (berdazimer topical gel, 10.3%) is the first FDA-approved at-home prescription treatment for molluscum contagiosum. It was approved by the FDA in January 2024 and became commercially available in July 2025 through Pelthos Therapeutics.
Before Zelsuvmi, there was no FDA-approved topical treatment that patients could use at home for molluscum. Treatment options were limited to in-office procedures like cryotherapy (freezing) and curettage (scraping), or off-label use of other medications.
Zelsuvmi is approved for the topical treatment of molluscum contagiosum (MC) in adults and children 1 year of age and older.
Molluscum contagiosum is a common viral skin infection caused by the molluscum contagiosum virus (MCV), a type of poxvirus. It causes small, firm, flesh-colored or pink bumps on the skin, often with a dimple in the center.
Key facts about molluscum:
While molluscum isn't dangerous, it can be embarrassing, uncomfortable, and frustrating — especially for children who may be excluded from activities like swimming.
Zelsuvmi is a nitric oxide-releasing agent. When applied to molluscum bumps, it releases nitric oxide (NO) directly onto the lesions. Nitric oxide has antiviral properties that help fight the virus by:
For a deeper dive into the science, read our guide on how Zelsuvmi works.
Zelsuvmi comes as a kit with two tubes that must be mixed before each use:
Do not use Zelsuvmi if you are allergic to berdazimer or any ingredient in the formulation. Tell your doctor about any allergies before starting treatment.
In clinical trials, Zelsuvmi demonstrated that it can clear molluscum lesions when used as directed over 12 weeks. Results vary — some patients see significant improvement, while others may need the full 12-week course or additional treatment.
It's important to set realistic expectations:
Zelsuvmi's cash price is approximately $1,910 to $2,350 per kit (31g total — Tube A 14g + Tube B 17g). No generic version is currently available.
For a full breakdown, see our guide on how to save money on Zelsuvmi.
The most common side effects are skin reactions at the application site:
Most side effects are mild and temporary. For the full breakdown, including when to call your doctor, read our Zelsuvmi side effects guide.
How does Zelsuvmi compare to other options for molluscum?
| Treatment | Type | Where Used | Key Difference |
|---|---|---|---|
| Zelsuvmi | Topical gel (Rx) | At home | First FDA-approved at-home option |
| Ycanth (Cantharidin) | Topical solution (Rx) | Doctor's office | Applied by provider only; causes blistering |
| Cryotherapy | Procedure | Doctor's office | Freezing; requires multiple visits; can be painful |
| Curettage | Procedure | Doctor's office | Scraping; effective but painful; may scar |
| Imiquimod (Aldara) | Topical cream (Rx) | At home | Off-label use; not specifically approved for MC |
For more on alternatives, see our guide to alternatives to Zelsuvmi.
Zelsuvmi is available at:
Not every pharmacy stocks it. Use MedFinder to find pharmacies near you with Zelsuvmi available, or read our guide on how to check if a pharmacy has Zelsuvmi in stock.
Zelsuvmi is a game-changer for molluscum contagiosum treatment. It's the first medication that lets patients treat molluscum bumps at home with an FDA-approved topical gel. While it's not cheap and not at every pharmacy, savings programs and expanding insurance coverage are making it more accessible in 2026.
Talk to your doctor to find out if Zelsuvmi is right for you or your child.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.